308 related articles for article (PubMed ID: 4351501)
1. The influence of oral contraceptive steroids on serum lipids.
De Alvarez RR; Jahed FM; Spitalny KJ; Elkin H; Jaunakais I
Am J Obstet Gynecol; 1973 Jul; 116(5):727-49. PubMed ID: 4351501
[TBL] [Abstract][Full Text] [Related]
2. Comparative studies of the ethynyl estrogens used in oral contraceptives. VII. Effects with and without progestational agents on ultracentrifugally fractionated plasma lipoproteins in humans, baboons, and beagles.
Goldzieher JW; Chenault CB; de la Peña A; Dozier TS; Kraemer DC
Fertil Steril; 1978 Nov; 30(5):522-33. PubMed ID: 214353
[TBL] [Abstract][Full Text] [Related]
3. Effect of estrogen/progestin potency on lipid/lipoprotein cholesterol.
Wahl P; Walden C; Knopp R; Hoover J; Wallace R; Heiss G; Rifkind B
N Engl J Med; 1983 Apr; 308(15):862-7. PubMed ID: 6572785
[TBL] [Abstract][Full Text] [Related]
4. Oral contraceptive and postmenopausal estrogen effects on lipoprotein triglyceride and cholesterol in an adult female population: relationships to estrogen and progestin potency.
Knopp RH; Walden CE; Wahl PW; Hoover JJ; Warnick GR; Albers JJ; Ogilvie JT; Hazzard WR
J Clin Endocrinol Metab; 1981 Dec; 53(6):1123-32. PubMed ID: 7298796
[TBL] [Abstract][Full Text] [Related]
5. A two-year clinical study of the effects of two triphasic oral contraceptives on plasma lipids.
Kakis G; Powell M; Marshall A; Woutersz TB; Steiner G
Int J Fertil Menopausal Stud; 1994; 39(5):283-91. PubMed ID: 7820162
[TBL] [Abstract][Full Text] [Related]
6. Comparison of metabolic and clinical effects of four oral contraceptive formulations and a contraceptive vaginal ring.
Roy S; Mishell DR; Gray G; Dozono-Takano R; Brenner PF; Eide I; de Quattro V; Shaw ST
Am J Obstet Gynecol; 1980 Apr; 136(7):920-31. PubMed ID: 6767404
[TBL] [Abstract][Full Text] [Related]
7. Progestins and oral contraceptive-induced lipoprotein changes: a prospective study.
Lipson A; Stoy DB; LaRosa JC; Muesing RA; Cleary PA; Miller VT; Gilbert PR; Stadel B
Contraception; 1986 Aug; 34(2):121-34. PubMed ID: 3096633
[TBL] [Abstract][Full Text] [Related]
8. Comparative studies of the ethynyl estrogens used in oral contraceptives. III. Effect on plasma gonadotropins.
Goldzieher JW; de la Peña A; Chenault CB; Cervantes A
Am J Obstet Gynecol; 1975 Jul; 122(5):625-36. PubMed ID: 1146928
[TBL] [Abstract][Full Text] [Related]
9. Cross-reaction of contraceptive steroids in competitive binding assays of progesterone and estradiol.
Kharma K; Stone S; Thorneycroft IH; Nakamura RM; Mishell DR
Am J Obstet Gynecol; 1972 Mar; 112(5):676-80. PubMed ID: 4110418
[TBL] [Abstract][Full Text] [Related]
10. [Influence of progestins on adverse effects of oral contraceptives].
Wynn V
Contracept Fertil Sex (Paris); 1985 Jan; 13(1 Suppl):425-30. PubMed ID: 12280210
[TBL] [Abstract][Full Text] [Related]
11. The effect of progestins in combined oral contraceptives on serum lipids with special reference to high-density lipoproteins.
Wynn V; Niththyananthan R
Am J Obstet Gynecol; 1982 Mar; 142(6 Pt 2):766-71. PubMed ID: 6801982
[TBL] [Abstract][Full Text] [Related]
12. Metabolic effects of contraceptive steroids. I. Observations of blood lipids.
Devi PK; Sharma R
J Asian Fed Obstet Gynaecol; 1972 Dec; 3(2):95-100. PubMed ID: 12310411
[TBL] [Abstract][Full Text] [Related]
13. Serum lipids and lipoproteins during treatment with oral contraceptives containing natural and synthetic oestrogens. A controlled double-blind investigation.
Bostofte E; Hemmingsen L; Møller KJ; Serup J; Weber T
Acta Endocrinol (Copenh); 1978 Apr; 87(4):855-64. PubMed ID: 347855
[TBL] [Abstract][Full Text] [Related]
14. Invluence of oral contraceptives on circulating immune response. II. Effect of progestogenic and estrogenic components.
Rangnekar KN; Rao SS; Joshi UM
Contraception; 1974 Nov; 10(5):527-33. PubMed ID: 4141295
[TBL] [Abstract][Full Text] [Related]
15. A randomized comparative open study of the effects of two oral contraceptives, Triphasil and Ortho 7/7/7, on lipid metabolism.
Kakis G; Powell M; Marshall A; Steiner G
Contraception; 1993 Feb; 47(2):131-48. PubMed ID: 8449014
[TBL] [Abstract][Full Text] [Related]
16. Effects of oral contraceptives on lipoprotein triglyceride and cholesterol: relationships to estrogen and progestin potency.
Knopp RH; Walden CE; Wahl PW; Hoover JJ
Am J Obstet Gynecol; 1982 Mar; 142(6 Pt 2):725-31. PubMed ID: 7065054
[TBL] [Abstract][Full Text] [Related]
17. [Changes in plasma lipids caused by oral contraceptives].
Kaffarnik H
Z Ernahrungswiss Suppl; 1972; 12():Suppl 12:67-72. PubMed ID: 4114609
[No Abstract] [Full Text] [Related]
18. Liver function tests in patients on oral progestogens.
Engineer AD; Gupta V; Tandon P
J Obstet Gynaecol India; 1968 Apr; 18(2):598-605. PubMed ID: 12331828
[TBL] [Abstract][Full Text] [Related]
19. The effect of various contraceptive hormonal therapies in women with normal and diabetic oral glucose tolerance test.
Aznar R; Lara R; Zarco D; González L
Contraception; 1976 Mar; 13(3):299-311. PubMed ID: 55331
[TBL] [Abstract][Full Text] [Related]
20. Control of fertility with oral medication.
Diddle AW; Watts GF; Gardner WH; Williamson PJ
West J Surg Obstet Gynecol; 1964; 72():222-9. PubMed ID: 12305556
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
